Table 1

Baseline characteristics and changes in biomedical variables after 1 year in both treatment groups.

Routine care (n = 243)Intensive treatment (n = 255)P-valuea
Baseline1 yearBaseline1 year
Demographic variables
 Sex, % male56.051.8
 Age in years, mean (SD)59.9 (5.1)60.1 (5.4)
 Ethnicity, % white98.798.0
Behavioural variables
 Current smoking, %21.426.3
 Ever smoked, %68.066.1
 Drinking alcohol, %78.178.4
 Weekly >5 pieces of fruit, %61.757.6
 Exercise (days per week >30 min), mean (SD)3.8 (2.5)4.0 (2.3)
Clinical variables, mean (SD)
 Body mass index, kg/m230.4 (4.6)30.6 (4.8)31.2 (5.1)29.8 (4.8)<0.001
 Systolic blood pressure, mmHg163 (23)144 (17)166 (23)133 (17)<0.001
 Diastolic blood pressure, mmHg89 (10)82 (8)90 (11)78 (9)<0.001
Biochemical variables, mean (SD)
 Fasting blood glucose, mmol/l8.1 (2.8)7.2 (1.7)7.8 (2.3)6.5 (1.1)0.02
 HbA1c, %7.4 (1.7)6.5 (0.9)7.3 (1.6)6.2 (0.6)0.03
 Cholesterol, mmol/l5.6 (1.1)5.1 (1.0)5.6 (1.1)4.4 (0.9)<0.001
 HDL-cholesterol, mmol/l1.1 (0.3)1.2 (0.9)1.1 (0.4)1.1 (0.3)0.26
 LDL-cholesterol, mmol/l3.7 (1.0)3.2 (1.0)3.7 (1.0)2.7 (0.8)<0.001
 Triglycerides, mmol/l2.0 (1.6)1.7 (1.7)1.9 (1.0)1.5 (0.8)0.71
Practices, %
 Single-handed50.043.2
 Urban location52.429.7
 Specific diabetes clinic63.462.2
 >10% patients from ethnic minority groups7.18.1
  • a Comparison of changes in variables between treatment groups adjusted for age, sex, baseline value, and clustering at practice level. HbA1c = Haemoglobin A1c. HDL = high-density lipoprotein. LDL = low-density lipoprotein.